Debra Richardson to CD47 Antigen
This is a "connection" page, showing publications Debra Richardson has written about CD47 Antigen.
Connection Strength
0.245
-
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer. J Immunother Cancer. 2025 Jan 11; 13(1).
Score: 0.245